ConductScience.org, home

Paper7540952

The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.

Pili R and 5 others. Cancer Res, 1995. Cited by 151 papers, by iCite.

Cite this record

ConductScience Library. The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth. Papers, record 7540952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7540952

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The alpha-glucosidase I inhibitor castanospermine alters endothelial cell glycosylation, prevents angiogenesis, and inhibits tumor growth.
PubMed
Journal
Cancer Res
PubMed
Year
1995
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
151
iCite
Relative citation ratio, by iCite
4.25
iCite
Revised in PubMed
2026-01-28
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pili RR
2Chang JJ
3Partis RAR A
4Mueller RAR A
5Chrest FJF J
6Passaniti AA

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
EndotheliumMajor topic
GlycoconjugatesMajor topic
Glycoside Hydrolase InhibitorsMajor topic
GlycosylationMajor topic
IndolizinesMajor topic
Neoplasms, ExperimentalMajor topic
Neovascularization, PathologicMajor topic
1-Deoxynojirimycin
Animals
Cell Adhesion
Cell Aggregation
Cell Differentiation
Cell Division
Cells, Cultured
Chemotaxis
Glucosamine
Growth Inhibitors
In Vitro Techniques
Mice
Mice, Inbred C57BL
Mice, Nude
Protein Processing, Post-Translational
Indolizidines

Source PubMed

Download CSV of topics

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 151 citations.

PMIDTitleJournalYearIn PapersSource
42762413Integrative multi-omics analysis identifies LIPA as a prognostic hub and ferroptosis regulator in lung adenocarcinoma.Mol Cell Biochem2026https://conductscience.org/library/papers/42762413PubMed
41286166Design, synthesis, pharmacological evaluation and computational modeling of 4-formyl-2-nitrophenyl quinoline-8-sulfonate derived thiosemicarbazones as antidiabetic agents.J Comput Aided Mol Des2025https://conductscience.org/library/papers/41286166PubMed
40891620Domino Grignard Addition/Cope-House Reaction for the Synthesis of Polyhydroxylated 3-Methylindolizidines Analogous to Castanospermine.Org Lett2025https://conductscience.org/library/papers/40891620PubMed
40661216Synthesis and multi-target antiproliferative evaluation of novel 1,2,4-triazole-3-thione analogues against breast cancer: in silico and in vitro mechanistic insights.RSC Adv2025https://conductscience.org/library/papers/40661216PubMed
39595931Enzyme (α-Glucosidase, α-Amylase, PTP1B & VEGFR-2) Inhibition and Cytotoxicity of Fluorinated Benzenesulfonic Ester Derivatives of the 5-Substituted 2-Hydroxy-3-nitroacetophenones.Int J Mol Sci2024https://conductscience.org/library/papers/39595931PubMed
39456508Exploring the 3,5-Dibromo-4,6-dimethoxychalcones and Their Flavone Derivatives as Dual α-Glucosidase and α-Amylase Inhibitors with Antioxidant and Anticancer Potential.Antioxidants (Basel)2024https://conductscience.org/library/papers/39456508PubMed
39098853Glycosylation: mechanisms, biological functions and clinical implications.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39098853PubMed
38982268Design, synthesis, in vitro, and in silico anti-α-glucosidase assays of N-phenylacetamide-1,2,3-triazole-indole-2-carboxamide derivatives as new anti-diabetic agents.Sci Rep2024https://conductscience.org/library/papers/38982268PubMed
38362162BIRTH OF A GLYCOTHERAPY FOR BREAST CANCER.Trends Carbohydr Res2023https://conductscience.org/library/papers/38362162PubMed
38001824In Vitro α-Glucosidase and α-Amylase Inhibition, Cytotoxicity and Free Radical Scavenging Profiling of the 6-Halogeno and Mixed 6,8-Dihalogenated 2-Aryl-4-methyl-1,2-dihydroquinazoline 3-Oxides.Antioxidants (Basel)2023https://conductscience.org/library/papers/38001824PubMed
37623885Deciphering Molecular Aspects of Potential α-Glucosidase Inhibitors within Aspergillus terreus: A Computational Odyssey of Molecular Docking-Coupled Dynamics Simulations and Pharmacokinetic Profiling.Metabolites2023https://conductscience.org/library/papers/37623885PubMed
36282858Peptide Lv augments intermediate-conductance calcium-dependent potassium channels (KCa3.1) in endothelial cells to promote angiogenesis.PLoS One2022https://conductscience.org/library/papers/36282858PubMed
35732907Design, synthesis, in vitro α-glucosidase inhibition, docking, and molecular dynamics of new phthalimide-benzenesulfonamide hybrids for targeting type 2 diabetes.Sci Rep2022https://conductscience.org/library/papers/35732907PubMed
35731990Deepening the knowledge of rare diseases dependent on angiogenesis through semantic similarity clustering and network analysis.Brief Bioinform2022https://conductscience.org/library/papers/35731990PubMed
35454076Glycotherapy: A New Paradigm in Breast Cancer Research.Biomolecules2022https://conductscience.org/library/papers/35454076PubMed
35002739Elevated N-Glycosylation Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Cells Revealed by Membrane Proteomic and Glycoproteomic Analysis.Front Pharmacol2021https://conductscience.org/library/papers/35002739PubMed
33303737Inhibition of protein glycosylation is a novel pro-angiogenic strategy that acts via activation of stress pathways.Nat Commun2020https://conductscience.org/library/papers/33303737PubMed
33209651Nanoformulation enhances anti-angiogenic efficacy of tunicamycin.Transl Cancer Res2013https://conductscience.org/library/papers/33209651PubMed
33092246Evaluation of Cytotoxicity and α-Glucosidase Inhibitory Activity of Amide and Polyamino-Derivatives of Lupane Triterpenoids.Molecules2020https://conductscience.org/library/papers/33092246PubMed
31698979Newly Identified Peptide, Peptide Lv, Promotes Pathological Angiogenesis.J Am Heart Assoc2019https://conductscience.org/library/papers/31698979PubMed

See all 53 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7540952

GET https://conductscience.org/api/papers/v1/7540952/cited_by?page=2